Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 • 7,165 citations
Global and societal implications of the diabetes epidemic
2001 • 5,825 citations
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 • 5,471 citations
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
2000 • 3,103 citations
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
1999 • 2,051 citations
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 • 1,592 citations
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
1999 • 1,472 citations
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
2000 • 1,224 citations
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
2000 • 923 citations
Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice
2000 • 378 citations
Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study
1995 • 329 citations
Discussion
1997 • 315 citations
A Clinical Approach for the Diagnosis of Diabetes Mellitus
1996 • 304 citations
Characteristics of 9194 Patients With Left Ventricular Hypertrophy
1998 • 296 citations
A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels
1996 • 245 citations
Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/β-Blocker–Based Treatment Regimen
2001 • 222 citations
Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients
2000 • 202 citations
H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study
1997 • 186 citations
No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malm� Preventive Trial with diet and exercise
1998 • 183 citations
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)
2001 • 160 citations
Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes
2001 • 134 citations
Screening for diabetes in general practice: cross sectional population study
2001 • 113 citations
A Model for Early Diagnosis of Type 2 Diabetes Mellitus in Primary Health Care
1993 • 66 citations
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study
2000 • 60 citations
Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population
2001 • 42 citations
Cited By (0)
No citing papers found in database